Tuesday, September 18, 2018
Company News: Page (1) of 1 - 03/27/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Providence, Rhode Island, Carving the Path to Reduced Opioid Death Rates After Testing a Medical for Addiction Treatment (MAT) Program on Inmates

(March 27, 2018)

SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Heroin Detox Clinics completes new informational page about heroin drug rehabs and substance abuse in Providence RI. The new article explains that simple detox has about a 90 percent failure rate.  Opioid addicted inmates go through involuntary detox once they are incarcerated.  But they are not given any tools for complete rehabilitation for when they get out.  Opioid users build up a tolerance for the quantity needed for the same high.  Upon release, they go right back to the amount they used upon going into jail which results in a very high rate of overdose deaths.  Their bodies can no longer tolerate the higher dosage. 

According to the Substance Abuse and Mental Health Services Administration (SAMSHA), successful sobriety has been aided by using FDA-approved medications along with proven therapies allowing the user to remain in recovery and treatment long enough to get the help they need.  Providence began their program in 2016 finding opioid addicted inmates and using the MAT procedure which resulted in a 61 percent decrease in post incarceration overdose deaths.  Could this become the model for the nation in reducing opioid related overdose deaths?   Dr. Josiah “Jody” Rich, professor of medicine and epidemiology at Brown University and director of the Center for Prisoner Health and Human Rights at The Miriam Hospital in Providence believes that this program can definitely reduce the mortality rate of opioid deaths. Heroin rehabs in Providence offer help for struggling addicts to recover from opiate addiction.

Three different types of drug therapies were used by the Rhode Island Department of Corrections (RIDOC).  Naltrexone is a drug that blocks people from experiencing the feeling of getting high therefore reducing their desire for the opioids but this drug can only be taken once the person has detoxed and should be used as a part of a complete treatment program that includes monitoring, counseling, behavioral contract and lifestyle changes.  The two other drugs used are methadone and buprenorphine which are opioid medications that help reduce the withdrawal symptoms. Each patient is evaluated and given the treatment that fits them as an individual.

Two more very important parts of this program was using CODAC Behavioral Health, a nonprofit provider of medications for addiction treatment, that provide and administer MAT inside the correction facilities.  Once the inmate is released, they are able to continue their treatment without interruption.  Primary care providers, Centers of Excellence in MAT as well as CODAC will continue to treat the individual.  Re-enrolling in a health insurance plan that will cover treatment is also supported to ensure they will stay in the program and remain on the sobriety path to becoming a productive part of the community.

Author: William Leonard

Organization: HeroinDetoxClinics.com Address: 27420 Jefferson Ave, Temecula, CA 92590

Phone: 888-325-2454

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/70b3c620-4e8f-486a-8a4b-f1e05c4dc83c

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   DMN Newswire ,   HTN - Health Technology Net ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Tutorial Finder ,   Review Seeker ,   Review Seeker ,   DMN Newswire Newsletter ,   DMN Newswire Newsletter

  • Brain Ischemia Market Analysis 2018-2023 | Increased Prevalence Rate with Topmost Players ThromboGenics, Vernalis, Neurotec Pharma, Covidien and Others - Asserts MRFR
  • IV Infusion Pump Accessories Market is poised to register a CAGR of 4.5% by 2025 – Persistence Market Research
  • Effie Chow Qigong Healing System Available On Mediterranean Celebrity Cruise Line Says Sharon Kleyne & Rose Hong
  • The Methuselah Foundation Successfully Closes its Boutique Venture Fund, the Methuselah Fund, Focused on Companies That Can Extend the Healthy Human Lifespan
  • Report on CPH by Research Dynamics: Investor Day update

  • Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
  • Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US
  • Chardan Advises NovellusDX in Cross-Border Biotech Merger
  • Eroll Grow Tech (Seedo) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged Company
  • Chemotherapy-Induced Nausea & Vomiting (CINV) Treatment - Worldwide Markets to 2026: A $3.62 Billion Opportunity

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines